GILD vs PAHC · P/E 18, rev $7.80B vs P/E 13, rev $1.52B
Gilead Sciences Inc (GILD) versus Phibro Animal Health Corporation (PAHC) — a side-by-side from cached financials, not a winner call.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US. It is led by Daniel P. O'Day.
Phibro Animal Health Corporation (PAHC) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported GILD revenue for 2026-06-30 was $7.80B. Net income was -$10.50B. Revenue was up 12.1% from 2026-03-31 to 2026-06-30. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Latest reported PAHC revenue for 2026-06-30 was $1.52B. Net income was $99.7M. Revenue was up 17.1% from 2025-06-30 to 2026-06-30. PAHC currently screens at market cap $1.25B and trailing P/E 13.2.
GILD currently screens at market cap $160.15B and trailing P/E 17.5. PAHC currently screens at market cap $1.25B and trailing P/E 13.2.
Not investment advice. Open the GILD and PAHC stock pages for the full models.
Not investment advice.